Maria Siemionow
Fondateur chez Dystrogen Therapeutics Corp.
Postes actifs de Maria Siemionow
Sociétés | Poste | Début | Fin |
---|---|---|---|
Dystrogen Therapeutics Corp.
Dystrogen Therapeutics Corp. Packaged SoftwareTechnology Services Dystrogen Therapeutics Corp. develops platform for therapies of rare genetic diseases. The company was founded by Kris Siemionow, Maria Siemionow, and Paul Lewicki in 2017 and is headquartered in Chicago, IL. | Directeur Technique/Scientifique/R&D | 01/01/2017 | - |
Fondateur | 01/01/2017 | - |
Historique de carrière de Maria Siemionow
Anciens postes connus de Maria Siemionow
Sociétés | Poste | Début | Fin |
---|---|---|---|
Tolera Therapeutics, Inc.
Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tolera Therapeutics, Inc. develops novel therapies and technologies for immune modulation. Its products include anti-aßTCR antibody an immune induction therapy in solid organ transplantation and graft versus host disease. The company was founded by Jake Orville, Maria Siemionow, James J. Herrmann and John J. Puisis in 2007 and is headquartered in Ann Arbor, MI. | Directeur Technique/Scientifique/R&D | 20/09/2010 | - |
Fondateur | 20/09/2010 | - |
Statistiques
Internationale
Etats-Unis | 3 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Sectorielle
Commercial Services | 2 |
Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Tolera Therapeutics, Inc.
Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tolera Therapeutics, Inc. develops novel therapies and technologies for immune modulation. Its products include anti-aßTCR antibody an immune induction therapy in solid organ transplantation and graft versus host disease. The company was founded by Jake Orville, Maria Siemionow, James J. Herrmann and John J. Puisis in 2007 and is headquartered in Ann Arbor, MI. | Commercial Services |
Dystrogen Therapeutics Corp.
Dystrogen Therapeutics Corp. Packaged SoftwareTechnology Services Dystrogen Therapeutics Corp. develops platform for therapies of rare genetic diseases. The company was founded by Kris Siemionow, Maria Siemionow, and Paul Lewicki in 2017 and is headquartered in Chicago, IL. | Technology Services |
- Bourse
- Insiders
- Maria Siemionow
- Expérience